DE3877621D1 - Trockene orale theophyllinzubereitung mit verzoegerter freisetzung. - Google Patents

Trockene orale theophyllinzubereitung mit verzoegerter freisetzung.

Info

Publication number
DE3877621D1
DE3877621D1 DE8888107863T DE3877621T DE3877621D1 DE 3877621 D1 DE3877621 D1 DE 3877621D1 DE 8888107863 T DE8888107863 T DE 8888107863T DE 3877621 T DE3877621 T DE 3877621T DE 3877621 D1 DE3877621 D1 DE 3877621D1
Authority
DE
Germany
Prior art keywords
release
formulation
delayed release
dry oral
oral theophylline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888107863T
Other languages
English (en)
Other versions
DE3877621T2 (de
Inventor
Richard Chang
Robert P Giannini
Charles Hsaio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DE3877621D1 publication Critical patent/DE3877621D1/de
Application granted granted Critical
Publication of DE3877621T2 publication Critical patent/DE3877621T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8888107863T 1987-05-18 1988-05-17 Trockene orale theophyllinzubereitung mit verzoegerter freisetzung. Expired - Fee Related DE3877621T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/051,095 US4786509A (en) 1987-05-18 1987-05-18 Dry sustained release theophylline oral formulation

Publications (2)

Publication Number Publication Date
DE3877621D1 true DE3877621D1 (de) 1993-03-04
DE3877621T2 DE3877621T2 (de) 1993-05-13

Family

ID=21969313

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888107863T Expired - Fee Related DE3877621T2 (de) 1987-05-18 1988-05-17 Trockene orale theophyllinzubereitung mit verzoegerter freisetzung.

Country Status (8)

Country Link
US (1) US4786509A (de)
EP (2) EP0291923B1 (de)
JP (1) JPH02501738A (de)
AT (1) ATE84711T1 (de)
DE (1) DE3877621T2 (de)
ES (1) ES2043722T3 (de)
GR (1) GR3007347T3 (de)
WO (1) WO1988009167A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
ES2287126T3 (es) 2000-04-27 2007-12-16 Verion Inc. Microcapsulas de liberacion de orden cero y controladas por la temperatura y procedimiento para su preparacion.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3488418A (en) * 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US4587118A (en) * 1981-07-15 1986-05-06 Key Pharmaceuticals, Inc. Dry sustained release theophylline oral formulation
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
EP0291923A1 (de) 1988-11-23
US4786509A (en) 1988-11-22
GR3007347T3 (de) 1993-07-30
EP0291923B1 (de) 1993-01-20
ATE84711T1 (de) 1993-02-15
EP0358710A1 (de) 1990-03-21
JPH02501738A (ja) 1990-06-14
DE3877621T2 (de) 1993-05-13
WO1988009167A1 (en) 1988-12-01
ES2043722T3 (es) 1994-01-01

Similar Documents

Publication Publication Date Title
NO863061L (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
IT1164548B (it) Forme galeniche di somministrazione di medicamenti per via orale,a liberazione programmata,e loro procedimenti di preparazione
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO821645L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoazepinderivater
NO171367C (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO170155C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater
NO802015L (no) Fremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
NO166281C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,1-disubstituerte cyklopropanderivater.
ATE34300T1 (de) Theophyllin mit verlaengerter abgabe.
ATE84711T1 (de) Trockene orale theophyllinzubereitung mit verzoegerter freisetzung.
NO893909L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
NO164542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)-pyrimidinderivater.
IE873367L (en) Ranitidine-ethanol formulation
NO171857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater
IT7950847A0 (it) Derivati amminici dotati di attivi ta' farmacologica e procedimento per la loro preparazione
NO891114D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
TR27058A (tr) 2-azabisiklo (2,2,1) hept-5-ene-2 asetik asid bunun türevleri ve ilgili bilesimleri mezkur bilesimlerin hazirlanmasi usul ve mezkur bilesimlerin n-fosfonometilglisin imali icin kullanilmasi.
IE893578L (en) Phenyloxypropanolamine derivatives, their preparation and¹their application in therapeutics
NO860091L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino(4[,5[:3,4)pyrrolo(2,1-a)isokinolin-derivater.
NO893768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2,7-diamino-1,2,3,4-tetrahydronaftalenderivater.
NO833770L (no) Fremgangsmaate for fremstilling av terapeutisk aktive (1,2,4) triazolo (4,3-a) kinoksalin-4-amin-derivater
NO852741L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklopenta (b)tiofen-6-karboksylsyre-derivater
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee